Featured Product
This Week in Quality Digest Live
FDA Compliance Features
Del Williams
Options to address the risk of combustible dust explosions for NFPA 61 compliance
Doug Folsom
Unpatched vulnerabilities will become increasingly susceptible to cyberattacks
Del Williams
Mitigate risk, prevent safety issues by utilizing closed conveyor systems designed with sanitation in mind
Dirk Dusharme @ Quality Digest
Companies say they plan to pull some or all of their devices
Dirk Dusharme @ Quality Digest
First step, migrate your QMS to a cloud-based electronic quality management system

More Features

FDA Compliance News
Company’s first funding round will be used to accelerate product development for its QMS and MES SaaS offerings
Showcasing tech, solutions, and services at Gulfood Manufacturing 2022
Easy, reliable leak testing with methylene blue
Now is not the time to skip critical factory audits and supply chain assessments
Google Docs collaboration, more efficient management of quality deviations
Delivers time, cost, and efficiency savings while streamlining compliance activity
First trial module of learning tool focuses on ISO 9001 and is available now
Free education source for global medical device community
Good quality is adding an average of 11 percent to organizations’ revenue growth

More News


FDA Compliance

ISPE Releases Guide on Electronic Records and Signatures Good Practices

Published: Tuesday, April 26, 2005 - 21:00

(ISPE: Tampa, FL) -- The International Society for Pharmaceutical Engineering (ISPE) announced the availability of its newest technical publication, “GAMP Good Practices Guide: A Risk-Based Approach to Compliant Electronic Records and Signatures.” The guide is a user-friendly manual that covers the appropriate management of electronic records and signatures. It’s the newest edition to ISPE’s GAMP Good Practice Guide Series, developed by the GAMP Forum, a technical subcommittee of ISPE. It supplements the existing “Good Manufacturing Practice (GAMP) Guide for Validation of Automated Systems in Pharmaceutical Manufacture—GAMP 4.”

The main section of the guide provides a process by which a regulated company can identify the hazards associated with the use of electronic records and signatures, analyze and evaluate risks, control risks, and monitor the effectiveness of the controls via periodic review.

For more information, visit www.ispe.org.


About The Author

ISPE’s picture


The International Society for Pharmaceutical Engineering (ISPE) is a global nonprofit association of 22,000 pharmaceutical professionals in 90 countries who use knowledge to create high-quality, cost-effective good manufacturing practices (GMP) solutions. ISPE provides its members opportunities to develop technical knowledge, exchange practical experience within their community, enhance their professional skills, and collaborate with global regulatory agencies and industry leaders. Founded in 1980, ISPE offers online learning for a global audience. Its world headquarters are in Tampa, Florida, with offices in Brussels, Belgium, Shanghai, China, and Singapore.